|
gptkbp:instanceOf
|
U.S. federal law provision
|
|
gptkbp:administeredBy
|
gptkb:Health_Resources_and_Services_Administration
|
|
gptkbp:appliesTo
|
covered entities
|
|
gptkbp:codifiedIn
|
gptkb:42_U.S.C._§_256b
|
|
gptkbp:coveredEntitiesInclude
|
gptkb:Ryan_White_HIV/AIDS_Program_grantees
gptkb:rural_referral_centers
gptkb:sole_community_hospitals
children's hospitals
critical access hospitals
disproportionate share hospitals
federally qualified health centers
|
|
gptkbp:dateEnacted
|
1992
|
|
gptkbp:discountsApplyTo
|
outpatient drugs
|
|
gptkbp:enactedBy
|
gptkb:United_States_Congress
|
|
gptkbp:excludes
|
inpatient drugs
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Section 340B
|
|
gptkbp:partOf
|
gptkb:Public_Health_Service_Act
|
|
gptkbp:purpose
|
to require drug manufacturers to provide outpatient drugs to eligible health care organizations at reduced prices
|
|
gptkbp:relatedTo
|
gptkb:Medicaid_Drug_Rebate_Program
|
|
gptkbp:requires
|
drug manufacturers to provide discounts
|
|
gptkbp:subjectOf
|
policy debates on drug pricing
regulatory oversight by HRSA
litigation involving drug manufacturers and hospitals
|
|
gptkbp:bfsParent
|
gptkb:340B_Drug_Pricing_Program
|
|
gptkbp:bfsLayer
|
6
|